Местоположение
Поиск по объявлениям
Выберите категорию
Марка автомобиля
Тип кузова
Год выпуска
Пробег, тыс. км.
Коробка передач
Тип двигателя
Объём двигателя, л.
Привод
Владельцев по ПТС
Вид техники
Вид техники
Вид техники
Вид товара
Вид объекта
Тип дома
Вид объекта
Количество комнат
Вид объекта
Общая площадь, м2
Материал стен
Этаж
Этажей в доме
Лоджия/балкон
Санузел
Категория земель
Площадь участка, сот.
Расстояние до города, км
Сфера деятельности
График работы
Опыт работы
Стаж работы, лет
Образование
Пол
Возраст, лет
Вид услуги
Вид одежды
Вид одежды
Вид товара
Вид товара
Вид товара
Вид товара
Вид товара
Вид товара
Вид товара
Вид товара
Вид товара
Вид товара
Вид товара
Вид телефона
Вид товара
Вид товара
Вид товара
Вид велосипеда
Вид товара
Вид товара
Вид товара
Вид товара
Порода
Порода
Вид животного
Вид бизнеса
Вид оборудования
Тип объявления
Цена, руб.
Сортировка по
Настройки поиска
  • Тип автомобиля: С пробегом
  • Марка: Mercedes-Benz
  • Тип кузова: Седан
  • Год выпуска: 2011
  • Пробег: 204 тыс. км.
  • Коробка передач: Автомат
  • Тип двигателя: Бензин
  • Привод: Передний
  • Владельцев по ПТС: 1
Адрес: Абхазия, Сухум,
Mercedes-Benz Е-класс 3.0 turbo, дизель Год 2011 Пробег 204 Авто из Германии. В отличном состоянии. Пробег родной
  • 1 843
  • 1
  • 7-04-2023, 06:15
-5
900 000

Hyundai H-1 2.5 AT, 2012

Сухум

23-08-2025, 13:12
2 500 000
1 300 000

Авто в Абхазии. Kia Carnival 2015

Сухум

23-03-2025, 20:53
750 000
750 000
510 000

Авто из Абхазии. Honda Freed RS

Сухум

13-07-2024, 19:39
Комментарии (1)
Написать
  • bowtiesmilelaughingblushsmileyrelaxedsmirk
    heart_eyeskissing_heartkissing_closed_eyesflushedrelievedsatisfiedgrin
    winkstuck_out_tongue_winking_eyestuck_out_tongue_closed_eyesgrinningkissingstuck_out_tonguesleeping
    worriedfrowninganguishedopen_mouthgrimacingconfusedhushed
    expressionlessunamusedsweat_smilesweatdisappointed_relievedwearypensive
    disappointedconfoundedfearfulcold_sweatperseverecrysob
    joyastonishedscreamtired_faceangryragetriumph
    sleepyyummasksunglassesdizzy_faceimpsmiling_imp
    neutral_faceno_mouthinnocent
Кликните на изображение чтобы обновить код, если он неразборчив
Cheri Cheri
0
BPC‑157 is a synthetic peptide that has attracted attention for its potential regenerative properties.

It is derived from a naturally occurring protein in the stomach and is
composed of 15 amino acids. Researchers have explored BPC‑157 primarily in animal models
where it has shown promise in accelerating tissue repair, reducing inflammation, and protecting organs such as the gut,
liver, and heart from injury.



About this item

BPC‑157 is typically supplied as a lyophilized powder that can be reconstituted with sterile water or saline
for injection. The peptide is marketed to researchers and
clinicians who are investigating its therapeutic potential
in conditions ranging from tendon and ligament injuries to inflammatory bowel disease.

Because it is not approved by major regulatory agencies for human use,
it is often sold as a research chemical rather than a pharmaceutical product.

Users must handle the peptide with care, following strict sterility
protocols to avoid contamination.



Skip to

For those interested in the practical aspects of BPC‑157, the next
sections cover dosage considerations, administration routes, and
safety notes that have emerged from preclinical studies.

It is also useful to understand how the peptide interacts at a cellular level,
influencing growth factors such as vascular endothelial growth factor (VEGF) and transforming growth factor beta
(TGF‑β). These mechanisms are believed to underlie its capacity to promote healing
in a wide array of tissues.



Sorry, there was a problem.

If you encounter difficulties with sourcing or
handling BPC‑157, the most common issues involve mislabeling of product purity and confusion over reconstitution volumes.

Because it is sold primarily as a research compound, quality control can vary
between suppliers. Users should verify batch certificates and perform their own assays
when possible to confirm peptide integrity. Additionally, legal restrictions
differ by country; in many regions BPC‑157 remains unapproved for therapeutic use, which may affect its
availability and the legitimacy of sales channels.





Overall, while BPC‑157 shows encouraging results in animal models,
more rigorous human studies are needed to establish safety profiles, optimal dosing regimens, and long‑term effects.
Researchers who wish to explore this peptide should stay informed about evolving regulations and maintain meticulous documentation throughout their investigations.


References:


amazon